Compare

Burning Rock Biotech Ltd vs Concord Medical Services Holdings Ltd

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Burning Rock Biotech Ltd BNR	Concord Medical Services Holdings Ltd CCM
Year ended	2025-12-31	2025-12-31
Revenue	539.57M CNY	460.51M CNY
Revenue growth (YoY)	+4.6%	+19.9%
Gross margin	74.7%	5.6%
Operating margin	-10.2%	-56.8%
Net margin	-10.3%	-20.2%
Net income	-55.35M CNY	-92.81M CNY
EPS (Diluted)	n/a	-0.71 CNY
Operating cash flow	-28.44M CNY	-201.82M CNY
Free cash flow	-33.69M CNY	-258.15M CNY
Cash & equivalents	478.39M CNY	297.79M CNY
Total assets	820.38M CNY	6.55B CNY
Total liabilities	285.11M CNY	4.70B CNY
Shareholders' equity	535.26M CNY	1.85B CNY
Return on year-end equity	-10.3%	-5.0%
Shares outstanding	n/a	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Burning Rock Biotech Ltd	Concord Medical Services Holdings Ltd
Latest	539.57M CNY Ended 2025-12-31	460.51M CNY Ended 2025-12-31
1 year earlier	515.82M CNY Ended 2024-12-31	383.96M CNY Ended 2024-12-31
2 years earlier	537.43M CNY Ended 2023-12-31	537.40M CNY Ended 2023-12-31
3 years earlier	563.24M CNY Ended 2022-12-31	472.08M CNY Ended 2022-12-31
4 years earlier	507.86M CNY Ended 2021-12-31	485.63M CNY Ended 2021-12-31